insights_auto
Why is RDHL up 4.39%?
Dive Deeperchevron_right
RDHL:NASDAQ
RedHill Biopharma Ltd
$0.50
arrow_upward
+4.39%(+0.021) 1D
$0.49
arrow_downward
-2.04% (-0.010)todayPre-market
Closed: Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RDHL...
Open
$0.50
High
$0.51
Low
$0.49
Mkt. cap
4.46M
Avg. vol.
699.97K
Volume
102.00
P/E ratio
0.63
52-wk high
$2.14
52-wk low
$0.44
EPS
$0.80
Beta
4.91
Shares outstanding
8.89M
No. of employees
13
Open
$0.50
High
$0.51
Low
$0.49
Mkt. cap
4.46M
Avg. vol.
699.97K
Volume
102.00
P/E ratio
0.63
52-wk high
$2.14
52-wk low
$0.44
EPS
$0.80
Beta
4.91
Shares outstanding
8.89M
No. of employees
13
News stories
From web sources and news partners
Stock Titan
·
20 hours ago
A five-year cancer grant is planned to fund RedHill Biopharma (RDHL) drug trials.
About RedHill Biopharma Ltd
CEODror Ben Asher
Employees13
Founded2009
Headquarters-
SectorPharmaceutical industry
Websiteredhillbio.com